6 lucky numbers for capricorn today

6 lucky numbers for capricorn today 1 / 6 Reliance Infrastructure | The company's unit, PS Toll Road Private Ltd, received notices from Axis Bank and IDFC First Bank on Friday. The two banks have invoked the right of substitution under the Concession Agreement for six-laning the Pune Satara section of NH-44 in Maharashtra, for and on behalf of lenders of the PSTR citing alleged DSRA defaults by it. 2 / 6 Axis Max Life Insurance | The insurer's unit, Max Life Pension Fund Management Ltd (Max Life PFM), announced plans to discontinue its operations as a pension fund manager and a point of presence under regulations set by the Pension Fund Regulatory and Development Authority (PFRDA). The decision follows a brand-related ambiguity between Max Life PFM and Axis Pension Fund Management Limited (Axis PFM), a pension fund management entity within Axis Bank’s group. 3 / 6 JSW Energy | The energy behemoth announced the acquisition of O2 Power, a renewable energy platform, in a transaction valued at ₹12,468 crore, marking its largest acquisition since inception. The deal will significantly expand JSW Energy’s generation capacity by 23%, increasing it from 20,012 megawatt (MW) to 24,708 MW. 4 / 6 Utkarsh Small Finance Bank | The lender said it will sell a portfolio of non-performing assets (NPAs) and written-off loans to an asset reconstruction company (ARC). The portfolio under consideration consists of unsecured stressed microfinance institution (MFI) loans with an aggregate outstanding principal of approximately ₹355 crore as of September 30, 2024. 5 / 6 IOL Chemicals | The company's board approved to split the company's shares in the proportion of 1 share into 5 shares. This means that for every stock investors hold in the company, it will be subdivided into 5 shares. 6 / 6 Hero MotoCorp | India’s largest two-wheeler maker extended its partnership with US-based premium motorcycle maker Harley-Davidson Motor to co-develop and manufacture a new motorcycle as well as expand the existing co-developed model - X440 - into new variants.The Washington Commanders put kicker Austin Seibert on injured reserve Tuesday, just over 48 hours since he missed an extra point that would have tied the score with 21 seconds left against Dallas. Seibert also missed a field-goal attempt and another extra point in the loss to the Cowboys. He missed the previous two games with a right hip injury but said afterward he was fine and made the decision to play. The Commanders filled that roster spot by signing running back Chris Rodriguez Jr. off their practice squad. Austin Ekeler had a concussion and Brian Robinson Jr. sprained an ankle Sunday. AP NFL: https://apnews.com/hub/nfl

US drone firm appoints Trump Jr as adviser and sees stock price soar - The Guardian US

Ange Postecoglou searching for answers over Tottenham’s injury crisis

Johnson & Johnson JNJ , the iconic healthcare giant known for its stable dividends and defensive appeal, has entered a bearish technical pattern: the Death Cross . This occurs when the stock's 50-day moving average falls below its 200-day moving average, signaling potential downside. Chart created using Benzinga Pro JNJ Stock Chart: Bearish Signals Abound JNJ stock, at $145.58, is below critical moving averages across the board. Its 20-day ($144.97), 50-day ($154.24) and 200-day ($154.66) moving averages suggest the trend is firmly bearish. With a MACD of a negative 2.72 and a Relative Strength Index of 36.84, the technical setup doesn't inspire confidence. The one silver lining? JNJ stock's eight-day simple moving average of $144.97 is slightly below its current price, flashing a rare bullish signal amid the gloom. Read Also: FDA Rejects Johnson & Johnson’s Injectable Version Of Approved Drug For Lung Cancer Johnson & Johnson’s Strategic Moves In Dermatology While the charts tell one story, Johnson & Johnson's business narrative points to another. The company recently inked a licensing deal with Kaken Pharmaceutical for KP-723, a promising candidate targeting atopic dermatitis (AD), also known as eczema. With plans to launch a phase I study in 2025, Johnson & Johnson is positioning itself to address significant unmet needs in autoimmune and allergic diseases. This move aligns with the company's strategic focus on differentiated mechanisms of action in dermatology. Johnson & Johnson's acquisitions in 2024 also bolstered its dermatology pipeline, emphasizing innovative treatments for AD and other immune-mediated conditions. Dividend Reliability Meets Bearish Momentum Johnson & Johnson's long-standing reputation as a dividend aristocrat—boasting 60+ years of consistent payouts—continues to provide a safety net for investors. With ample liquidity, low leverage, and robust free cash flow, the company's dividend sustainability remains solid even in the face of technical bearishness. The Verdict The Death Cross may cast a shadow over Johnson & Johnson stock's short-term outlook, but its commitment to growth, innovation, and reliable dividends underscores its long-term appeal. Investors should weigh JNJ stock’s bearish technical indicators against the company's strategic moves in dermatology and its history of weathering market storms. As Johnson & Johnson looks to tackle eczema and diversify its portfolio, the stock may be down but far from out. For now, the Death Cross is a storm cloud on the horizon—but every storm eventually passes. Read Next: Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025 Photo by Tada Images via Shutterstock . © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Johnson Matthey Plc ( OTCPK:JMPLF ) Q2 2025 Earnings Conference Call November 27, 2024 4:00 AM ET Company Participants Martin Dunwoodie - Director of Investor Relations Liam Condon - Chief Executive Stephen Oxley - Chief Financial Officer Anish Taneja - Chief Executive, Clean Air and Chair, Group Commercial Council Maurits van Tol - Chief Executive, Catalyst Technologies Conference Call Participants Tristan Lamotte - Deutsche Bank Sebastian Bray - Berenberg Bank Ranulf Orr - Citi Charlie Bentley - Jefferies Martin Dunwoodie Good morning, everyone. I'm Martin Dunwoodie, Director of Investor Relations here at Johnson Matthey. Thank you everyone for coming along today and for those of you who have tuned in on the webcast. A little bit of admin before we start. [Operator Instructions] We're going to follow the usual format today. So we'll have a presentation followed by Q&A. And we'll take the Q&A first from the room then the webcast. And I'd say, I'm very pleased to welcome today Liam Condon, our CEO; and Stephen Oxley, our CFO. I'll point to our cautionary statement as usual. And with that, I'll hand over to Liam for the presentation. Liam Condon So thanks a lot, Martin, and a warm welcome to everybody here at the London Stock Exchange, and of course a very warm welcome to everybody who is joining us online today. As Martin said, I will give a brief introduction, say a little bit about what's happening in our markets and what's happening at JM in the past six months. Stephen is going to talk you through the financials. I'll give you an update on our strategic progress, and then we'll have most of the time available for Q&A, which we are very much looking forward to. So if we get straight into it, what you've seen from our results that weTuning DBMS: The Secret Life of Queries and Runtime Data

Arsenal up to second after Kai Havertz goal sees off struggling Ipswich

HMC's Heart Hospital performs robotic coronary artery bypass graft surgeries

Happy Thanksgiving Eve, everyone. While Thanksgiving is usually a happy holiday, it can also get a bit awkward at the dinner table, when politics are brought up. This year could be especially bad, considering we're just weeks removed from the results of the 2024 presidential election, when Donald Trump topped Kamala Harris, winning 312 Electoral College votes. One USA TODAY writer is even suggesting that President Biden "cancel" Thanksgiving this year, due to the heated political climate . "In the wake of the presidential election," Huppke writes . "The last thing any of us need to be doing is walking into potentially volatile mixed-ideology settings that often feature alcohol, long-standing feelings of familial resentment and easily thrown pies." While that's obviously an overreaction, it often does get political at the Thanksgiving dinner table. But everyone in the Manning family is probably on the same side, at least that we know of. Jeff Bottari/Getty Images Peyton and Eli Manning have made it pretty clear where they stand politically over the years. The two legendary NFL quarterbacks have reportedly shown support for the Republican Party. Peyton Manning has appeared at GOP events and donated to Republican Party candidates, while Eli Manning has admitted to being friendly with Donald Trump. Peyton Manning, a two-time Super Bowl champion and one of the best players of the 21st century, has reportedly been a "longstanding" donor to the party. The legendary NFL quarterback had reportedly been a "longstanding" supporter of the Republican Party. He had reportedly donated close to $20,000 to Republican candidates, according to USA TODAY. Manning reportedly donated to past presidential candidates like Mitt Romney and Jeb Bush. The latter of which joked about Manning's support following the Super Bowl. NFL fans, meanwhile, aren't too shocked by this. After all, the Manning family grew up in the South, attending SEC schools and has made a lot of money. It doesn't take a rocket scientist to guess that they are probably right-leaning. "Two rich guys who grew up in the south with a rich dad. Wow it’s a big surprise," one NFL fan wrote. "I care , I'm glad they are smart enough to support the Republican candidates...USA USA...," one fan added. Instagram. Thanksgiving Weekend will be a special one for the Manning family this year, too. Texas, where Arch Manning plays, is set to take on Texas A&M in a special rivalry game on Saturday. ESPN's College GameDay will be broadcasting live from the campus of Texas A&M on Saturday morning.